Information Society in PharmaceuticalsOrganizations contemplate information technology and the Internet as a unique opportunity to enhance knowledge work and to improve quality of service. Electronic regulatory reporting, electronic document archival and data retrieval, automatic transactions between collaborative enterprise resources, wide availability and dissemination of information to the public; these are a few of the facets enabled by the information society and the digital revolution. |
Comentarios de la gente - Escribir un comentario
No encontramos ningún comentario en los lugares habituales.
Contenido
Sección 1 | 11 |
Sección 2 | 17 |
Sección 3 | 25 |
Sección 4 | 37 |
Sección 5 | 49 |
Sección 6 | 59 |
Sección 7 | 64 |
Sección 8 | 75 |
Sección 9 | 107 |
Sección 10 | 109 |
Otras ediciones - Ver todas
Términos y frases comunes
activities administration adverse drug reactions adverse event adverse reactions AERS CDER Centres for Study clinical trial coding communication consumers COSTART data elements database Document Type Definition documents dossier drug dictionary E-mail eBusiness eCTD EFPIA electronic format electronic safety reporting electronic submission electronic transmission EMEA ESTRI EudraNet EudraSafe EudraVigilance European Commission European Union Evaluation of Medicinal exchange global Group guidelines Harmonisation ICHE2B ICSRs identify implementation individual case safety initiatives integrated International Internet IOS Press issues Japan joint pilot legacy terminology marketing authorisation MedDRA medicinal products MSSO organisations paper pharma pharmaceutical companies pharmaceutical industry Pharmaceutical Law pharmacovigilance pharmacovigilance information pharmacovigilance system Prefectural Government procedures provides regulators regulatory agencies regulatory authorities regulatory information safety message secure sender SGML specific Stan van Belkum standards Study of Pharmaceutical Telematics transmission of individual users validation